Kelly Schick
Human Resources Officer at C4 THERAPEUTICS, INC.
Net worth: 326 046 $ as of 30/04/2024
Kelly Schick active positions
| Companies | Position | Start | End |
|---|---|---|---|
| C4 THERAPEUTICS, INC. | Human Resources Officer | 12/01/2021 | - |
ScripNet LLC
 ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - | - |
Career history of Kelly Schick
Former positions of Kelly Schick
| Companies | Position | Start | End |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2011 | - |
| AMAG PHARMACEUTICALS, INC. | Human Resources Officer | 01/09/2016 | - |
Training of Kelly Schick
| Boston University | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Graduate Degree |
Statistics
International
| United States | 5 |
| Belgium | 2 |
| 2 |
Operational
| Corporate Officer/Principal | 2 |
| Human Resources Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 3 |
|---|---|
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Technology Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| C4 Therapeutics, Inc. |
- Stock Market
- Insiders
- Kelly Schick
- Experience